1 White CJ Jaff MR Haskal ZJ . Indications for renal arteriography at the time of coronary arteriography: a science advisory from the American Heart Association Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology, and the Councils on Cardiovascular Radiology and Intervention and on Kidney in Cardiovascular Disease. Circulation2006; 114: 1892–1895.
2.
2 Wilson JMG Jungner G . Principles and practice of screening for disease.Geneva: World Health Organization, 1968.
3.
3 Rihal CS Textor SC Breen JF . Incidental renal artery stenosis among a prospective cohort of hypertensive patients undergoing coronary angiography. Mayo Clin Proc2002; 77: 309–316.
4.
4 Buller CE Nogareda JG Ramanathan K . The profile of cardiac patients with renal artery stenosis. J Am Coll Cardiol2004; 43: 1606–1613.
5.
5 Harding MB Smith LR Himmelstein SI . Renal artery stenosis: prevalence and associated risk factors in patients undergoing routine cardiac catheterization. J Am Soc Nephrol1992; 2: 1608–1616.
6.
6 Leertouwer TC Pattynama PM van den Berg-Huysmans A . Incidental renal artery stenosis in peripheral vascular disease: a case for treatment? Kidney Int2001; 59: 1480–1483.
7.
7 Pearce JD Craven BL Craven TE . Progression of atherosclerotic renovascular disease: a prospective population-based study. J Vasc Surg2006; 44: 955–962; discussion 962–963.
8.
8 Crowley JJ Santos RM Peter RH . Progression of renal artery stenosis in patients undergoing cardiac catheterization. Am Heart J1998; 136: 913–918.
9.
9 Harvey RT Soulen MC Siegelman ES . Impact of screening MR angiography on referrals for percutaneous intervention in renovascular disease. J Vasc Interv Radiol1999; 10: 559–564.
10.
10 Axelrod DA Fendrick AM Birkmeyer JD Wennberg DE Siewers AE . Cardiologists performing peripheral angioplasties: impact on utilization. Eff Clin Pract2001; 4: 191–198.
11.
11 Murphy TP Soares G Kim M . Increase in utilization of percutaneous renal artery interventions by Medicare beneficiaries, 1996–2000. AJR Am J Roentgenol2004; 183: 561–568.
12.
12 Zeller T Frank U Muller C . Stent-supported angioplasty of severe atherosclerotic renal artery stenosis preserves renal function and improves blood pressure control: long-term results from a prospective registry of 456 lesions. J Endovasc Ther2004; 11: 95–106.
13.
13 Lederman RJ Mendelsohn FO Santos R Phillips HR Stack RS Crowley JJ . Primary renal artery stenting: characteristics and outcomes after 363 procedures. Am Heart J2001; 142: 314–323.
14.
14 Radermacher J Chavan A Bleck J . Use of Doppler ultrasonography to predict the outcome of therapy for renal-artery stenosis. N Engl J Med2001; 344: 410–417.
15.
15 Silva JA Chan AW White CJ . Elevated brain natriuretic peptide predicts blood pressure response after stent revascularization in patients with renal artery stenosis. Circulation2005; 111: 328–333.
16.
16 Slovut D Lookstein R Bacharach JM Olin JW . Correlation between non-invasive and endovascular Doppler in patients with atherosclerotic renal artery stenosis: a pilot study. Catheter Cardiovasc Interv2006; 67: 426–433.
17.
17 Mahmud E Smith TWR Palakodeti V . Renal frame count and renal blush grade. J Am Coll Cardiol Intv2008; 1: 286–292.
18.
18 Suresh M Laboi P Mamtora H Kalra PA . Relationship of renal dysfunction to proximal arterial disease severity in atherosclerotic renovascular disease. Nephrol Dial Transplant2000; 15: 631–636.
19.
19 Leertouwer TC Derkx FH Pattynama PM Deinum J van Dijk LC Schalekamp MA . Functional effects of renal artery stent placement on treated and contralateral kidneys. Kidney Int2002; 62: 574–579.
20.
20 Rocha-Singh K Jaff MR Lynne Kelley E . Renal artery stenting with noninvasive duplex ultrasound follow-up: 3-year results from the RENAISSANCE renal stent trial. Catheter Cardiovasc Interv2008; 72: 853–862.
21.
21 Rodriguez-Lopez JA Werner A Ray LI . Renal artery stenosis treated with stent deployment: indications, technique, and outcome for 108 patients. J Vasc Surg1999; 29: 617–624.
22.
23.
24.
24 Marcus PM Bergstralh EJ Fagerstrom RM . Lung cancer mortality in the Mayo Lung Project: impact of extended follow-up. J Natl Cancer Inst2000; 92: 1308–1316.
25.
26.
26 Angioplasty and Stenting for Renal Artery Lesions (ASTRAL). Presented at SCAI-ACC i2 Summit/ACC 2008; Chicago, IL, USA.
27.
27 Gerbaud L Manhes G Debourse J . The appropriateness of renal angioplasty. The ANPARIA software: a multidisciplinary expert panel approach. Cardiovasc Intervent Radiol2008; 31: 1059–1068.
28.
28 Conlon PJ Little MA Pieper K Mark DB . Severity of renal vascular disease predicts mortality in patients undergoing coronary angiography. Kidney Int2001; 60: 1490–1497.
29.
29 Shishehbor MH Oliveira LP Lauer MS . Emerging cardiovascular risk factors that account for a significant portion of attributable mortality risk in chronic kidney disease. Am J Cardiol2008; 101: 1741–1746.
30.
30 Cambria RP Brewster DC L’Italien GJ . Renal artery reconstruction for the preservation of renal function. J Vasc Surg1996; 24: 371–380; discussion 380–382.
31.
31 Dorros G Jaff M Mathiak L . Four-year follow-up of Palmaz-Schatz stent revascularization as treatment for atherosclerotic renal artery stenosis. Circulation1998; 98: 642–647.
32.
32 Dorros G Jaff M Mathiak L He T . Multicenter Palmaz stent renal artery stenosis revascularization registry report: four-year follow-up of 1,058 successful patients. Catheter Cardiovasc Interv2002; 55: 182–188.
33.
33 McCullough PA Li S Jurkovitz CT . CKD and cardiovascular disease in screened high-risk volunteer and general populations: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999–2004. Am J Kidney Dis2008; 51: S38–S45.
34.
34 McCullough PA Jurkovitz CT Pergola PE . Independent components of chronic kidney disease as a cardiovascular risk state: results from the Kidney Early Evaluation Program (KEEP). Arch Intern Med2007; 167: 1122–1129.
35.
35 Coresh J Selvin E Stevens LA . Prevalence of chronic kidney disease in the United States. JAMA2007; 298: 2038–2047.
36.
36 Sarnak MJ Levey AS Schoolwerth AC . Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation2003; 108: 2154–2169.
37.
37 Khalique O Aronow WS Ahn C . Relation of moderate or severe reduction in glomerular filtration rate to number of coronary arteries narrowed >50% in patients undergoing coronary angiography for suspected coronary artery disease. Am J Cardiol2007; 100: 415–416.